In our study we identified three more podocyte markers with high gene expression such as GLEPP-1, ADAM10, and NFκB, which could be considered as additional candidate molecules of urinary podocyte biomarkers in early DN. This evidence concerns the gene PTPRO and liver dysplastic nodule.